Seelos Therapeutics (DE:NXEN)

Seelos Therapeutics Financial Statements


Seelos Therapeutics Financial Overview

Seelos Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Seelos Therapeutics is scheduled to report earnings on March 3, 2023, and the estimated EPS forecast is €-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -19.60M$ -21.27M$ -13.99M$ -27.25M$ -10.79M
EBITDA$ -19.60M$ -21.27M$ -13.99M$ -27.25M$ -10.79M
Net Income Common Stockholders$ -19.60M$ -21.27M$ -14.00M$ -27.26M$ -10.81M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 30.51M$ 41.25M$ 61.77M$ 78.73M$ 76.83M
Total Assets$ 40.51M$ 52.67M$ 70.69M$ 83.50M$ 80.95M
Total Debt$ 21.40M$ 19.27M$ 19.19M$ 18.96M$ 51.00K
Net Debt$ -9.11M$ -21.98M$ -42.58M$ -59.78M$ -76.78M
Total Liabilities$ 32.63M$ 26.44M$ 25.06M$ 26.18M$ 8.03M
Stockholders Equity$ 7.88M$ 26.23M$ 45.64M$ 57.32M$ 72.91M
Cash Flow
Free Cash Flow$ -11.07M$ -20.39M$ -17.05M$ -18.34M$ -10.51M
Operating Cash Flow$ -11.07M$ -20.39M$ -17.05M$ -18.34M$ -10.51M
Investing Cash Flow$ ―$ ―$ ―$ ―$ ―
Financing Cash Flow$ 334.00K$ -126.00K$ 83.00K$ 20.24M$ 143.00K
Currency in USD

Seelos Therapeutics Earnings and Revenue History

Seelos Therapeutics Debt to Assets

Seelos Therapeutics Cash Flow

Seelos Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis